Taken together, these results strongly indicate that IFN-β signaling plays a pivotal role in ASNS deficiency–mediated antitumor immune responses. Here, IFNB1 is linked to congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome.